News

Sahlgrenska science park companies, Ventrilabs growing IP portfolio and Detectivio’s ISO certification, these milestones show how different capabilities, built early and shape the journey from innovation to market.

On June 4, policymakers, healthcare leaders, patient representatives, researchers and industry experts from across Europe gathered at the European Parliament in Brussels to discuss one of the most pressing questions facing European healthcare and innovation policy: how can Europe accelerate patient access to innovation while strengthening its global competitiveness in life sciences?

CSW Therapeutics has reached an important new milestone, having been awarded its second MedTech4Health grant

The Center for Disaster Medicine is relocating to Medicinaregatan 8A, where Sahlgrenska Science Park operates the innovation hub within the property. The premises are located opposite the future Sahlgrenska Life district and bring together activities in research, education, and innovation.

The new cohort brings together startups working across regulatory, therapeutics, drug discovery & development, digital health strengthening the life science and healthtech ecosystem at Sahlgrenska Science Park.

Gothenburg-based Omaia has closed an oversubscribed pre-seed round backed by angel investors, reflecting growing investor interest in women’s health – a historically underfunded area despite significant unmet needs.